[2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug].
T
T
Robak
P
P
Grieb
D000328:Adult; D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000378:metabolism; D002648:Child; D017338:Cladribine / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007166:Immunosuppressive Agents; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy* / Q000378:metabolism; D051379:Mice
D007166:Immunosuppressive Agents; D017338:Cladribine
2-chlorodeoksyadenozyna (2-CDA)--nowy lek przeciwnowotworowy i immunosupresyjny.